Terms: = Head and neck cancer AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Treatment
1989 results:
1. Erythema dyschromicum perstans-like eruptions induced by epidermal growth factor receptor inhibitors in patients with lung cancer.
Bang AS; Said JT; Hirner J; Rana J; Pugliese S; Wang JY; Zaba L; Zhao L; Doan L; Smith J; Kwong BY
Support Care Cancer; 2024 May; 32(6):354. PubMed ID: 38750379
[TBL] [Abstract] [Full Text] [Related]
2. The involvement of epidermal growth factor receptor/protein kinase B signaling in the tumor intrinsic PD-L1-induced malignant potential of oral squamous cell carcinoma.
Sasabe E; Tomomura A; Yamamoto T
J Oral Pathol Med; 2024 May; 53(5):310-320. PubMed ID: 38693616
[TBL] [Abstract] [Full Text] [Related]
3. Dexrazoxane inhibits the growth of esophageal squamous cell carcinoma by attenuating SDCBP/MDA-9/syntenin-mediated egfr-PI3K-Akt pathway activation.
Du R; Xiao N; Han L; Guo K; Li K; Chen Z; Zhang H; Zhou Z; Huang Y; Zhao X; Bian H
Sci Rep; 2024 Apr; 14(1):9167. PubMed ID: 38649770
[TBL] [Abstract] [Full Text] [Related]
4. Decabromodiphenyl ether exposure reduces dabrafenib sensitivity of papillary thyroid carcinoma harboring BRAF
Wang X; Cui X; Wang Y; Wang Q; Sun F; Liu Z
Toxicology; 2024 May; 504():153807. PubMed ID: 38641160
[TBL] [Abstract] [Full Text] [Related]
5. Near-infrared imaging of head and neck squamous cell carcinoma using indocyanine green that targets the
Yuan Y; Fan T; Wang J; Yuan Y; Tao X
J Biomed Opt; 2024 Apr; 29(4):046002. PubMed ID: 38633382
[TBL] [Abstract] [Full Text] [Related]
6. The application of different machine learning models based on PET/CT images and egfr in predicting brain metastasis of adenocarcinoma of the lung.
Kong C; Yin X; Zou J; Ma C; Liu K
BMC Cancer; 2024 Apr; 24(1):454. PubMed ID: 38605303
[TBL] [Abstract] [Full Text] [Related]
7. New treatment Options for Patients With Oncogene-Addicted Non-Small Cell Lung cancer Focusing on
Saw SPL; Le X; Hendriks LEL; Remon J
Am Soc Clin Oncol Educ Book; 2024 Apr; 44(3):e432516. PubMed ID: 38560815
[TBL] [Abstract] [Full Text] [Related]
8. Microbiome Dysbiosis Is Associated with Castration Resistance and cancer Stemness in Metastatic Prostate cancer.
Uzelac M; Xin R; Ongkeko WM
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542265
[TBL] [Abstract] [Full Text] [Related]
9. Palbociclib inhibits the progression of head and neck cancer and improves the Cetuximab response under specific condition in vitro and in vivo.
Li R; Wang Q; Zhao Y; Zhu Y; Wang X
Mol Biol Rep; 2024 Mar; 51(1):455. PubMed ID: 38536540
[TBL] [Abstract] [Full Text] [Related]
10. egfr overexpression and macrophage infiltration correlate with poorer prognosis in HPV-negative oropharyngeal cancer via STAT6 signaling.
Lee HP; Li CJ; Lee CC
Head Neck; 2024 Jun; 46(6):1294-1303. PubMed ID: 38497289
[TBL] [Abstract] [Full Text] [Related]
11. [History and Perspective of Chemotherapy in Advanced Esophageal cancer].
Shiraishi K; Kato K
Gan To Kagaku Ryoho; 2024 Mar; 51(3):240-244. PubMed ID: 38494800
[TBL] [Abstract] [Full Text] [Related]
12. The antitumor effects of herbal medicine Triphala on oral cancer by inactivating PI3K/Akt signaling pathway: based on the network pharmacology, molecular docking, in vitro and in vivo experimental validation.
Hu S; Li S; Xu Y; Huang X; Mai Z; Chen Y; Xiao H; Ning W; Gaus S; Savkovic V; Lethaus B; Zimmerer R; Acharya A; Ziebolz D; Schmalz G; Huang S; Zhao J; Hu X
Phytomedicine; 2024 Jun; 128():155488. PubMed ID: 38493718
[TBL] [Abstract] [Full Text] [Related]
13. In vitro antimetastatic potential of pseudolaric acid B in HSC-3 human tongue squamous carcinoma cell line.
Yu HJ; Kim JH; Choi SJ; Cho SD
Arch Oral Biol; 2024 Jun; 162():105940. PubMed ID: 38479277
[TBL] [Abstract] [Full Text] [Related]
14. Lazertinib as a frontline treatment in patients with egfr-mutated advanced non-small cell lung cancer: Long-term follow-up results from LASER201.
Chul Cho B; Han JY; Hyeong Lee K; Lee YG; Kim DW; Joo Min Y; Kim SW; Kyung Cho E; Kim JH; Lee GW; Sook Lee S; Lee N; Young Wang J; Park H; Ahn MJ
Lung Cancer; 2024 Apr; 190():107509. PubMed ID: 38432025
[TBL] [Abstract] [Full Text] [Related]
15. Differential modulation of PI3K/Akt/mTOR activity by egfr inhibitors: A rationale for co-targeting egfr and PI3K in cisplatin-resistant HNSCC.
Liao J; Yang Z; Azarbarzin S; Cullen KJ; Dan H
Head Neck; 2024 May; 46(5):1126-1135. PubMed ID: 38429897
[TBL] [Abstract] [Full Text] [Related]
16. Salivary gland carcinoma: Towards a more personalised approach.
Rached L; Saleh K; Casiraghi O; Even C
Cancer Treat Rev; 2024 Mar; 124():102697. PubMed ID: 38401478
[TBL] [Abstract] [Full Text] [Related]
17. Dual anti-HER2/egfr inhibition synergistically increases therapeutic effects and alters tumor oxygenation in HNSCC.
Song PN; Lynch SE; DeMellier CT; Mansur A; Gallegos CA; Wright BD; Hartman YE; Minton LE; Lapi SE; Warram JM; Sorace AG
Sci Rep; 2024 Feb; 14(1):3771. PubMed ID: 38355949
[TBL] [Abstract] [Full Text] [Related]
18. Clinical impact of proteinuria on renal function and treatment outcomes in patients with radioiodine-refractory thyroid cancer treated with lenvatinib.
Fukuda N; Toda K; Suto H; Oki R; Wang X; Urasaki T; Sato Y; Nakano K; Ono M; Tomomatsu J; Mitani H; Takahashi S
Endocr J; 2024 Apr; 71(4):363-371. PubMed ID: 38296547
[TBL] [Abstract] [Full Text] [Related]
19. Immunohistochemical Expression of Epidermal Growth Factor Receptor (egfr) in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders.
Aamir R; Rauf F; Iqbal F; Yousuf S; Rehman A; Sheikh AK; Muhammad S
Appl Immunohistochem Mol Morphol; 2024 Mar; 32(3):157-162. PubMed ID: 38268382
[TBL] [Abstract] [Full Text] [Related]
20. Cyclic increase in the ADAMTS1-L1CAM-egfr axis promotes the EMT and cervical lymph node metastasis of oral squamous cell carcinoma.
Chien MH; Yang YC; Ho KH; Ding YF; Chen LH; Chiu WK; Chen JQ; Tung MC; Hsiao M; Lee WJ
Cell Death Dis; 2024 Jan; 15(1):82. PubMed ID: 38263290
[TBL] [Abstract] [Full Text] [Related]
[Next]
